The Neurobiology of Attention-Deficit/Hyperactivity Disorder

Biological Psychiatry

Volumn 61, Issue 12, 2007, Pages 1317-1319

  Chamberlain, Samuel R ^a   Robbins, Trevor W ^a   Sahakian, Barbara J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; DEXMETHYLPHENIDATE; DOPAMINE; METHYLPHENIDATE; MODAFINIL; NORADRENALIN; PLACEBO; PSYCHOSTIMULANT AGENT;

ATTENTION DEFICIT DISORDER; BRAIN SIZE; CAUDATE NUCLEUS; CEREBELLUM; CLINICAL FEATURE; CLINICAL TRIAL; CORPUS CALLOSUM; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EDITORIAL; GENOTYPE; HUMAN; NEUROBIOLOGY; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RIGHT HEMISPHERE;

ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBELLUM; CHILD; CORPUS STRIATUM; DOPAMINE; FRONTAL LOBE; HUMANS; IMPULSE CONTROL DISORDERS; METHYLPHENIDATE; NERVE NET; NOREPINEPHRINE; PROPYLAMINES; SYNAPTIC TRANSMISSION;

EID: 34249893675     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2007.04.009     Document Type: Editorial

References (30)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th ed. (1994), American Psychiatric Press, Washington, DC
2. Birnbaum H.G., Kessler R.C., Lowe S.W., Secnik K., Greenberg P.E., Leong S.A., et al. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: Excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin 21 2 (2005) 195-206
3. Biederman J. Attention-deficit/hyperactivity disorder: A selective overview. Biol Psychiatry 57 11 (2005) 1215-1220
4. Arnsten A.F. Fundamentals of attention-deficit/hyperactivity disorder: Circuits and pathways. J Clin Psychiatry 67 suppl 8 (2006) 7-12
5. Arnsten A.F. Stimulants: Therapeutic actions in ADHD. Neuropsychopharmacology 31 11 (2006) 2376-2383
6. Robbins T.W. Chemistry of the mind: Neurochemical modulation of prefrontal cortical function. J Comp Neurol 493 1 (2005) 140-146
7. Wilens T.E. Mechanism of action of agents used in attention-deficit/hyperactivity disorder. J Clin Psychiatry 67 suppl 8 (2006) 32-38
8. Volkow N.D. Stimulant medications: How to minimize their reinforcing effects?. Am J Psychiatry 163 3 (2006) 359-361
9. Bymaster F.P., Katner J.S., Nelson D.L., Hemrick-Luecke S.K., Threlkeld P.G., Heiligenstein J.H., et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27 5 (2002) 699-711
10. Wee S., and Woolverton W.L. Evaluation of the reinforcing effects of atomoxetine in monkeys: Comparison to methylphenidate and desipramine. Drug Alcohol Depend 75 3 (2004) 271-276
11. Robertson M.M. Attention deficit hyperactivity disorder, tics and Tourette's syndrome: The relationship and treatment implications. A commentary. Eur Child Adolesc Psychiatry 15 1 (2006) 1-11
12. Sangal R.B., Owens J., Allen A.J., Sutton V., Schuh K., and Kelsey D. Effects of atomoxetine and methylphenidate on sleep in children with ADHD. Sleep 29 12 (2006) 1573-1585
13. Greenhill L.L., Biederman J., Boellner S.W., Rugino T.A., Sangal R.B., Earl C.Q., et al. A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45 5 (2006) 503-511
14. Duteil J., Rambert F.A., Pessonnier J., Hermant J.F., Gombert R., and Assous E. Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur J Pharmacol 180 1 (1990) 49-58
15. Boonstra A.M., Kooij J.J., Oosterlaan J., Sergeant J.A., and Buitelaar J.K. Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD?. J Clin Exp Neuropsychol 27 3 (2005) 278-298
16. Eagle D.M., Tufft M.R., Goodchild H.L., Robbins T.W., and Buitelaar J.K. Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology (Berl) 192 2 (2007) 193-206
17. Chamberlain S.R., Muller U., Blackwell A.D., Clark L., Robbins T.W., and Sahakian B.J. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311 5762 (2006) 861-863
18. Turner D.C., Robbins T.W., Aron A.R., Dowson J., and Sahakian B.J. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) 165 3 (2003) 260-269
19. Aron A.R., Dowson J.H., Blackwell A.D., Sahakian B.J., and Robbins T.W. Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 54 12 (2003) 1465-1468
20. Turner D.C., Clark L., Dowson J., Robbins T.W., and Sahakian B.J. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry 55 10 (2004) 1031-1040
21. Chamberlain S.R., del Campo N., Dowson J., Muller U., Clark L., Robbins T.W., et al. Response inhibition in adults with attention-deficit hyperactivity disorder was improved by a single oral dose of atomoxetine. Biol Psychiatry (2007) (in press)
22. Chamberlain S.R., and Sahakian B.J. The neuropsychiatry of impulsivity. Curr Opin Psychiatry 20 3 (2007) 255-261
23. Dlugos A.M., Freitag C., Hohoff C., McDonald J., Cook E.H., Deckert J., et al. Norepinephrine transporter gene variation modulates acute response to D-amphetamine. Biol Psychiatry 61 11 (2007) 1296-1305
24. Durston S. A review of the biological bases of ADHD: What have we learned from imaging studies?. Ment Retard Dev Disabil Res Rev 9 3 (2003) 184-195
25. Seidman L.J., Valera E.M., and Makris N. Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry 57 11 (2005) 1263-1272
26. Castellanos F.X., Lee P.P., Sharp W., Jeffries N.O., Greenstein D.K., Clasen L.S., et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 288 14 (2002) 1740-1748
27. Seidman L.J., Valera E.M., Makris N., Monuteaux M.C., Boriel D.L., Kelkar K., et al. Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging. Biol Psychiatry 60 10 (2006) 1071-1080
28. Biederman J., Mick E., and Faraone S.V. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: Impact of remission definition and symptom type. Am J Psychiatry 157 5 (2000) 816-818
29. Aron A.R., Fletcher P.C., Bullmore E.T., Sahakian B.J., and Robbins T.W. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci 6 2 (2003) 115-116
30. Chambers C.D., Bellgrove M.A., Stokes M.G., Henderson T.R., Garavan H., Robertson I.H., et al. Executive "brake failure" following deactivation of human frontal lobe. J Cogn Neurosci 18 3 (2006) 444-455